Prodrugs of ER-beta-selective substances method for production thereof and pharmaceutical compositions comprising the same

Details for Australian Patent Application No. 2006319382 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Elger, Walter; Reddersen, Gudrun; Wyrwa, Ralf; Prelle, Katja; Droescher, Peter; Hillisch, Alexander; Peters, Olaf

Agent Davies Collison Cave

Pub. Number AU-A-2006319382

PCT Pub. Number WO2007/062876

Priority 10 2005 057 225.1 29.11.05 DE

Filing date 27 November 2006

Wipo publication date 7 June 2007

International Classifications

C07J 41/00 (2006.01) Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing nitrogen

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61P 5/30 (2006.01) Drugs for disorders of the endocrine system

Event Publications

24 July 2008 PCT application entered the National Phase

  PCT publication WO2007/062876 Priority application(s): WO2007/062876

16 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006319383-Prodrug ERbeta-selective substances, methods for the production thereof and pharmaceutical compositions containing said compounds

2006319381-Heteroaromatic sulfonamide prodrugs